This webinar will update on CLL first treatments today and what is on the horizon: how is a therapy chosen, how is prognosis determined and what level of involvement should patients expect in their care decisions.
The webinar seeks to explain the different types of intensive and non-intensive treatments, who can have a particular therapy, how they work, their efficacy and impact on daily living
We will be joined by:
Dr George Follows Consultant Haematologist at Cambridge University Hospitals Trust and
Visiting Professor of Haematology, Anglia Ruskin Medical School
Associate Lecturer, University of Cambridge
Dr Follow’s special interests are in chronic lymphocytic leukaemia (CLL);and lymphoma.
Helen Knight CLL specific CNS at Nottingham University Hospitals, Helen Knight is one of just a handful of CLL specific clinical nurse specialists across the UK.
John Perkins CLL patient perspective.
Liz Landers CLL patient perspective